Mirae Asset Global ETFs Holdings
CCCC icon

Mirae Asset Global ETFs Holdings’s C4 Therapeutics CCCC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+46,474
New +$159K ﹤0.01% 2447
2025
Q2 		– Sell
-35,241
Closed -$56.4K – 3044
2025
Q1 		$56.4K Buy
35,241
+1,566
+5% +$4.67K ﹤0.01% 2826
2024
Q4 		$121K Sell
33,675
-4,162
-11% -$20.7K ﹤0.01% 2622
2024
Q3 		$217K Buy
37,837
+30,844
+441% +$186K ﹤0.01% 2342
2024
Q2 		$32.3K Buy
+6,993
New +$41.7K ﹤0.01% 2863

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CCCC Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 46,474 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #2447 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in CCCC as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in CCCC in Q2 2024 and has held it in 5 quarters since. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 46,474 shares of C4 Therapeutics worth $217K as of Q2 2026.
  • C4 Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • C4 Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2447 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in C4 Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.